Thymic stromal lymphopoietin (TSLP) was identified more than 20 years ago as a secreted factor of a mouse thymic stromal cell line; later, a human orthologue was also identified. The signaling pathway triggered by TSLP has been extensively studied, and upregulation of the cytokine itself is linked to the pathogenesis of numerous Th2-related diseases, including atopic dermatitis, asthma, allergic responses, as well as certain types of cancers. On the other hand, TSLP mediates several immune homeostatic functions in both the gut and the thymus. Thus, a paradox occurs; why is TSLP homeostatic in certain tissues and a hallmark of exacerbated Th2 responses in the aforementioned pathologies? We and others have recently shown that in humans a novel isoform exists; this is a shorter isoform of TSLP whose expression is constitutive and controlled by a separate promoter. Short TSLP isoform mediates the homeostatic functions, whereas the long isoform is expressed at low/undetectable level at steady state and upregulated during inflammation in several tissues. Here we review the most recent data concerning the differential expression of the 2 isoforms and provide a potential explanation to the paradox. TSLP is regarded as a promising target for treatment of relevant pathologies, with a number of clinical trials already underway. It is important to design new strategies aimed at leaving intact the homeostatic effects of the short isoform while targeting the inflammatory effects of the long isoform. Thymic stromal lymphopoietin (TSLP) was identified more than 20 years ago as a secreted factor of a mouse thymic stromal cell line; later, a human orthologue was also identified. The signaling pathway triggered by TSLP has been extensively studied, and upregulation of the cytokine itself is linked to the pathogenesis of numerous Th2-related diseases, including atopic dermatitis, asthma, allergic responses, as well as certain types of cancers. On the other hand, TSLP mediates several immune homeostatic functions in both the gut and the thymus. Thus, a paradox occurs; why is TSLP homeostatic in certain tissues and a hallmark of exacerbated Th2 responses in the aforementioned pathologies? We and others have recently shown that in humans a novel isoform exists; this is a shorter isoform of TSLP whose expression is constitutive and controlled by a separate promoter. Short TSLP isoform mediates the homeostatic functions, whereas the long isoform is expressed at low/undetectable level at steady state and upregulated during inflammation in several tissues. Here we review the most recent data concerning the differential expression of the 2 isoforms and provide a potential explanation to the paradox. TSLP is regarded as a promising target for treatment of relevant pathologies, with a number of clinical trials already underway. It is important to design new strategies aimed at leaving intact the homeostatic effects of the short isoform while targeting the inflammatory effects of the long isoform. SummaryTSLP is a cytokine involved in a plethora of physiologic and pathologic immune functions, including tolerance and allergy. The existence of two isoforms of the protein whose expression is driven by independent promoters can explain these contrasting activities. TSLP is a cytokine involved in a plethora of physiologic and pathologic immune functions, including tolerance and allergy. The existence of two isoforms of the protein whose expression is driven by independent promoters can explain these contrasting activities. Cytokines (cyto, from Greek κύτταρο kyttaro “cell” + kines, from Greek κίνηση kinisi “movement”) are a broad category of small proteins whose release has an effect on the behavior of cells around them. They can act in an autocrine, paracrine, and/or endocrine fashion and are important in a number of biological processes including developmental processes during embryogenesis; however, they are particularly important in the regulation of immune responses. Cytokine types include chemokines, interferons (IFNs), lymphokines, interleukins (ILs), and tumor necrosis factors (TNFs). Because cytokines are important in intercellular and intracellular communications, they are produced by a broad range of cells such as fibroblasts, stromal, endothelial, or immune cells. They can be part of a physiological, homeostatic response or act as danger signals initiating inflammation in response to the detection of pathogens. Indeed, different isoforms of the same cytokine have been observed to mediate different effects according to the context, cellular source, and targets. These isoforms can be the result of alternative splicing, as is the case for IL15,1Onu A. Pohl T. Krause H. et al.Regulation of IL-15 secretion via the leader peptide of two IL-15 isoforms.J Immunol. 1997; 158: 255-262PubMed Google Scholar, 2Nishimura H. Yajima T. Naiki Y. et al.Differential roles of interleukin 15 mRNA isoforms generated by alternative splicing in immune responses in vivo.J Exp Med. 2000; 191: 157-170Crossref PubMed Scopus (132) Google Scholar or result from the expression of separate genes for each isoform, as is the case for the IFN, IL283Sheppard P. Kindsvogel W. Xu W. et al.IL-28, IL-29 and their class II cytokine receptor IL-28R.Nat Immunol. 2003; 4: 63-68Crossref PubMed Scopus (1309) Google Scholar and IL17.4Li H. Chen J. Huang A. et al.Cloning and characterization of IL-17B and IL-17C, two new members of the IL-17 cytokine family.Proc Natl Acad Sci U S A. 2000; 97: 773-778Crossref PubMed Scopus (278) Google Scholar Here we will examine how thymic stromal lymphopoietin (TSLP) belongs to the category of cytokines with more than 1 isoform, and we will review recent data that shed light on a paradox: despite the necessity for TSLP in the homeostatic development of certain immune cell subsets, the same cytokine seems to exert potent proinflammatory actions, and its upregulation underlies numerous allergic reactions and allergy-related pathologies. TSLP is an IL7-like cytokine initially discovered in the culture supernatant of a mouse thymic stromal cell line and shown to act as a growth factor for T and B cells.5Friend S.L. Hosier S. Nelson A. et al.A thymic stromal cell line supports in vitro development of surface IgM+ B cells and produces a novel growth factor affecting B and T lineage cells.Exp Hematol. 1994; 22: 321-328PubMed Google Scholar The existence of a human orthologue with similar functions was shown some years later by Quentmeier et al,6Quentmeier H. Drexler H.G. Fleckenstein D. et al.Cloning of human thymic stromal lymphopoietin (TSLP) and signaling mechanisms leading to proliferation.Leukemia. 2001; 15: 1286-1292Crossref PubMed Scopus (150) Google Scholar who observed constitutive TSLP expression in heart, lung, prostate, and testis human tissues. In the same study the authors cloned human TSLP and characterized the signaling pathway triggered by the TSLP–thymic stromal lymphopoietin protein receptor (TSLPR) interaction. In both human and mouse, the receptor for TSLP is a heterodimer composed of a chain specific for TSLP and the IL7R α-chain6Quentmeier H. Drexler H.G. Fleckenstein D. et al.Cloning of human thymic stromal lymphopoietin (TSLP) and signaling mechanisms leading to proliferation.Leukemia. 2001; 15: 1286-1292Crossref PubMed Scopus (150) Google Scholar, 7Park L.S. Martin U. Garka K. et al.Cloning of the murine thymic stromal lymphopoietin (TSLP) receptor: formation of a functional heteromeric complex requires interleukin 7 receptor.J Exp Med. 2000; 192: 659-670Crossref PubMed Scopus (326) Google Scholar, 8Pandey A. Ozaki K. Baumann H. et al.Cloning of a receptor subunit required for signaling by thymic stromal lymphopoietin.Nat Immunol. 2000; 1: 59-64Crossref PubMed Scopus (341) Google Scholar; however, in contrast to IL7, TSLP signaling results in JAK3-independent STAT5 phosphorylation.6Quentmeier H. Drexler H.G. Fleckenstein D. et al.Cloning of human thymic stromal lymphopoietin (TSLP) and signaling mechanisms leading to proliferation.Leukemia. 2001; 15: 1286-1292Crossref PubMed Scopus (150) Google Scholar, 7Park L.S. Martin U. Garka K. et al.Cloning of the murine thymic stromal lymphopoietin (TSLP) receptor: formation of a functional heteromeric complex requires interleukin 7 receptor.J Exp Med. 2000; 192: 659-670Crossref PubMed Scopus (326) Google Scholar Quentmeier et al observed that myeloid cells proliferate in response to human TSLP. These cell lines also upregulate granulocyte-macrophage colony-stimulating factor after conditioning; however, the authors demonstrate a direct effect of TSLP on the proliferation, independent from granulocyte-macrophage colony-stimulating factor and from the activity of mitogen-activated protein kinases (MAPKs).6Quentmeier H. Drexler H.G. Fleckenstein D. et al.Cloning of human thymic stromal lymphopoietin (TSLP) and signaling mechanisms leading to proliferation.Leukemia. 2001; 15: 1286-1292Crossref PubMed Scopus (150) Google Scholar TSLP also promotes the maturation of primary cells of myeloid origin, particularly CD11c+ dendritic cells (DCs), one of the subsets on expression of IL7R and is et thymic stromal lymphopoietin myeloid Immunol. 2001; PubMed Scopus Google Scholar, H. et cells dendritic cell allergic inflammation by Immunol. PubMed Scopus Google Scholar TSLP is expressed by cells and in the et thymic stromal lymphopoietin myeloid Immunol. 2001; PubMed Scopus Google Scholar and P. et thymic stromal lymphopoietin the and immune responses via and Th2 PubMed Scopus Google Scholar and seems to be involved in the regulation of inflammatory processes at the It is also produced by the cells of in the and dendritic cells to different types of T et dendritic cells to T cells in human PubMed Scopus Google Scholar, S. T. et stromal dendritic cells the of T cells in human Immunol. PubMed Scopus Google Scholar recent that other types of such as H. et cells dendritic cell allergic inflammation by Immunol. PubMed Scopus Google Scholar, Y. S. H. et thymic stromal lymphopoietin by human J. PubMed Scopus Google Scholar Thymic stromal lymphopoietin and Immunol. PubMed Scopus Google Scholar et al.A for the of T 2 Immunol. PubMed Scopus Google Scholar and Y. et stromal lymphopoietin is produced by dendritic Immunol. PubMed Scopus Google Scholar In can be of TSLP certain on in vitro of by and a upregulation of TSLP mRNA expression in a In with a for responses, TSLP by both and dendritic cells in the Y. et stromal lymphopoietin is produced by dendritic Immunol. PubMed Scopus Google Scholar more recent TSLP by human after with on The authors that is for TSLP and that this of both factor B and the et by dendritic cells is by and of the Immunol. PubMed Scopus Google Scholar for and the effects more et immune is by the cells and dendritic Immunol. PubMed Scopus Google Scholar, cells and the a for immune 2003; PubMed Scopus Google Scholar, of immune developmental and PubMed Scopus Google Scholar, T. et inflammatory in the of is dendritic cells and PubMed Scopus Google Scholar the effect of TSLP on immune responses its on was also It was observed that CD11c+ immune responses to a and Th2 T cells by the hallmark cytokines and whereas of the with potent and secretion or et dendritic cells by TSLP and T Exp Med. 2003; PubMed Scopus Google Scholar T cells with also a Th2 in the of H. et cells dendritic cell allergic inflammation by Immunol. PubMed Scopus Google Scholar, T. et dendritic cells an inflammatory T 2 cell response Exp Med. PubMed Scopus Google Scholar signals produced by the and secreted tissues cell subsets to the of are the of immune cells that to TSLP. 2 cells upregulate the hallmark Th2 cytokines and in response to TSLP or in with other P. et and 2 Immunol. PubMed Scopus Google Scholar On the TSLP on to Th2 cytokine secretion by the and cell is more in atopic from and is also for the development of inflammation in a mouse of the et cell responses to Med. PubMed Scopus Google Scholar In the is the and that promotes of 2 in response to such as et cells are a of Th2 cytokines in PubMed Scopus Google Scholar and as well as A. et 2 cells the to cell of Immunol. PubMed Scopus Google Scholar a upregulation of TSLP expression has been observed in mouse of atopic dermatitis, and J. D. et atopic in an thymic stromal lymphopoietin in the Exp Med. PubMed Scopus Google Scholar, T. et stromal lymphopoietin as a of allergic inflammation in Immunol. PubMed Scopus Google Scholar, et stromal responses Med. PubMed Scopus Google Scholar, et the immune for the of and immune Immunol. PubMed Scopus Google Scholar TSLP expression has been observed in in a is with responses in these et stromal responses Med. PubMed Scopus Google Scholar dermatitis, asthma, and allergic also TSLP expression in H. et cells dendritic cell allergic inflammation by Immunol. PubMed Scopus Google Scholar, S. J. et stromal lymphopoietin expression is in and with expression of and Immunol. PubMed Scopus Google Scholar, J. Y. et of thymic stromal lymphopoietin in allergic PubMed Scopus Google Scholar, et stromal lymphopoietin activity is in of with Immunol. PubMed Scopus Google Scholar, et stromal lymphopoietin and dendritic in with Immunol. PubMed Scopus Google Scholar whereas expression of is in these with the steady A. D. et dendritic cells are in allergic for thymic stromal of Th2 and PubMed Scopus Google Scholar, Huang et thymic stromal lymphopoietin receptor expression in with PubMed Scopus Google Scholar In the TSLP secretion by the and expression on target cells is the aforementioned proinflammatory activity of TSLP in such as and H. et cells dendritic cell allergic inflammation by Immunol. PubMed Scopus Google Scholar, S. J. et stromal lymphopoietin expression is in and with expression of and Immunol. PubMed Scopus Google Scholar the cytokine is also to be for the of and the development of in the that of 2 is independent of TSLP in the gut and is controlled by A. et thymic stromal lymphopoietin or is to and allergic Immunol. PubMed Scopus Google Scholar and the of such as and and have effects on expression of cytokines and in human Exp PubMed Scopus Google Scholar with and TSLP to upregulate secretion of and as well as the gut and on human in upregulation is by the of in the culture in a and have effects on expression of cytokines and in human Exp PubMed Scopus Google Scholar gut cell lines upregulate TSLP on with in a and this upregulation with growth to the of cells the of by H. cells the immune response to an of a of thymic stromal lymphopoietin and growth Google Scholar the for the to the of immune et immune is by the cells and dendritic Immunol. PubMed Scopus Google Scholar, et expression immune PubMed Scopus Google Scholar, W. A. et cells class a pathway by the Immunol. PubMed Scopus Google Scholar TSLP was identified as one of the produced by primary human cells for the of to a et cells the of dendritic PubMed Scopus Google Scholar In the we that supernatant from primary cells the of to expression in T cells. is observed cells from for and this is to the of TSLP expression in in cells of the we also that in the mouse, expression of in is for et cells dendritic cell Immunol. PubMed Scopus Google Scholar that TSLP is involved in development via in the mouse or that signaling the receptor is In the TSLP has also been shown to responses on T et cells TSLP that the of and Immunol. PubMed Scopus Google Scholar whereas of TSLP by a effect in the mouse of et effect of TSLP at the gut level by in mouse PubMed Scopus Google Scholar the same et A. et stromal expression of the mediates from PubMed Scopus Google Scholar observed and of whereas of the in also to to in this case is to the response to the of Th2 et and inflammation in mouse of and Exp Med. PubMed Scopus Google Scholar et et TSLP to Immunol. PubMed Scopus Google Scholar also that constitutive TSLP expression in the gut requires by and has an important in the of cells. The authors that in with the the is for the of and responses in this Thus, we have that expression of TSLP seems to be constitutive and homeostatic in certain an expression can to the development of a number of pathologies. of the cytokine also seems to be an of such as inflammation is and S. or the of a new and cells in the pathogenesis of PubMed Scopus Google Scholar The data a paradox in the of TSLP be specific in and homeostatic in gut and or the cytokine to the of by cell development or by exacerbated responses by to et and inflammation in mouse of and Exp Med. PubMed Scopus Google Scholar, S. et thymic stromal lymphopoietin and in PubMed Scopus Google Scholar the of TSLP to secretion by human a short of and is in the in et immune is by the cells and dendritic Immunol. PubMed Scopus Google Scholar, thymic stromal a novel cytokine and a potential in the of allergic PubMed Scopus Google Scholar the for regulation of the cytokine expression for its homeostatic effects to be The paradox of a for TSLP is also in other such as with a number of effects of TSLP on tumor growth and cell independent that TSLP expression by stromal or cells to tumor growth a in the et T 2 cell with thymic stromal lymphopoietin and in Exp Med. PubMed Scopus Google Scholar, A. Xu K. et stromal lymphopoietin human tumor growth by 2 Exp Med. PubMed Scopus Google Scholar for TSLP in tumor growth the regulation of the immune is also by other in mouse an of tumor growth in is Y. et stromal lymphopoietin is a of Immunol. PubMed Scopus Google Scholar, et of functional TSLP Th2 and the and growth of primary has different effects on in the and Immunol. PubMed Scopus Google Scholar more different in both the mouse and human a effect for TSLP for S. S. et stromal lymphopoietin of PubMed Scopus Google Scholar S. A. S. et thymic stromal lymphopoietin an in the 22: PubMed Scopus Google Scholar, U. et of immune responses the of inflammation from tumor to tumor 22: PubMed Scopus Google Scholar and W. Y. et stromal lymphopoietin (TSLP) human tumor growth by of tumor Google Scholar et U. et of immune responses the of inflammation from tumor to tumor 22: PubMed Scopus Google Scholar and et S. S. et stromal lymphopoietin of PubMed Scopus Google Scholar, S. A. S. et thymic stromal lymphopoietin an in the 22: PubMed Scopus Google Scholar demonstrate that the of the signaling tumor growth in different murine of TSLP are also with the clinical of In this et W. Y. et stromal lymphopoietin (TSLP) human tumor growth by of tumor Google Scholar that TSLP promotes the of human cells in a In et T. et of the thymic stromal lymphopoietin in human PubMed Scopus (132) Google Scholar the existence of 2 different for TSLP in human cells. In this the authors observed that a that was shown to upregulate et stromal lymphopoietin is by human cells in response to or inflammation and Exp Med. PubMed Scopus Google Scholar, A. S. et and Th2 of thymic stromal lymphopoietin in human Immunol. PubMed Scopus Google Scholar the upregulation of a long isoform of TSLP. shorter isoform, composed of the of the is expressed in human fibroblasts, and its expression is after with or It was initially that these 2 isoforms the result of alternative T. et of the thymic stromal lymphopoietin in human PubMed Scopus (132) Google Scholar 1 later, the same the existence of 2 in 2 different for TSLP in the human T. et stromal lymphopoietin are with to PubMed Scopus Google Scholar of the to the expression or of the 2 and the observed effects of TSLP have been to 1 of the 2 et al also 2 the long isoform that factor long TSLP These 2 with whereas this is for the is in the of the long T. et stromal lymphopoietin are with to PubMed Scopus Google Scholar these on cells and of the shown of TSLP in the of atopic diseases, et Y. T. Chen et TSLP expression and release of TSLP by and cytokines in human PubMed Scopus Google Scholar on to study the expression and differential of the 2 isoforms in human The they was to specific for the long isoform and the observed long TSLP expression with the TSLP The that for and upregulate long an effect in the of an atopic cytokine and On the and its upregulate long TSLP despite to a in the mouse TSLP P. et and thymic stromal lymphopoietin in mouse and an atopic Natl Acad Sci U S A. PubMed Scopus Google Scholar the authors that in steady TSLP are to more than long TSLP that the isoform expressed by human in steady state is the short was the potential activity of short TSLP. et A. T. et in the of the TSLP is for TSLP in human Immunol. PubMed Scopus Google Scholar that of cell lines with long TSLP in an in the authors identified several for and a long of the TSLP of the more results in an of the TSLP upregulation as observed in the same study the long isoform specific upregulation after of primary human with A. et for a functional thymic stromal lymphopoietin signaling in Immunol. 191: PubMed Scopus Google Scholar In with the data by et the upregulation of the long isoform was whereas expression of the short isoform after data the human and mouse also the of to TSLP expression and pathologies. In the et P. et and thymic stromal lymphopoietin in mouse and an atopic Natl Acad Sci U S A. PubMed Scopus Google Scholar that of are on the of an for the short isoform of TSLP is TSLP upregulation results in the development of an atopic P. et and thymic stromal lymphopoietin in mouse and an atopic Natl Acad Sci U S A. PubMed Scopus Google Scholar these results in the human in a more recent study that primary human and J. S. et is by and cytokines in human PubMed Scopus Google Scholar Here the authors TSLP by or with or by the relevant despite the upregulation of other target genes in these of TSLP is observed is to in that case the authors an of the they to the of other proinflammatory such as and S. et thymic stromal lymphopoietin and in PubMed Scopus Google Scholar this was a direct effect of or upregulation of a TSLP isoform was for the of proinflammatory activity was In an to the of TSLP isoforms in steady state and we the differential expression and activity of the 2 isoforms in vitro and in K. et of short and long thymic stromal lymphopoietin isoforms in inflammatory of the and Immunol. PubMed Scopus Google Scholar an in of the human TSLP we that the 2 isoforms are the result of alternative splicing of the same are controlled by 2 different We the and or promoters and as well as the to from of different cell a factor activity for the of the short isoform, whereas activity in the long isoform was we that in such as gut and short TSLP is the We that the short isoform of the protein on primary cells. In with these in has identified 1 receptor in of the TSLP of the short isoform We also for effects on TSLP secretion by human cells. such as and from upregulate the long isoform and the short isoform, whereas the is after with a that the observed in surface the homeostatic expression of TSLP. of a for the 2 isoforms of TSLP in the of the short isoform was et et short of TSLP is in human and has of an Immunol. PubMed Scopus Google Scholar the expression and activity of short TSLP on such as the and the Because the of the that short TSLP is to the of the long short are we have that to that the differential expression of the 2 isoforms been by chain with targeting one or the other In this the authors at the mRNA and they also a to the results at the protein TSLP with short TSLP to to the short isoform. this they that expression of TSLP on is to the short isoform, whereas long TSLP is upregulated in after with Because long TSLP been observed to exert A. et stromal lymphopoietin PubMed Scopus Google Scholar and this effect been to the of the the authors the activity of short TSLP and that the growth of was et short of TSLP is in human and has of an Immunol. PubMed Scopus Google Scholar on the functional of the 2 activity for short and the results that been in different and in the K. et of short and long thymic stromal lymphopoietin isoforms in inflammatory of the and Immunol. PubMed Scopus Google Scholar We the activity of the short isoform in vitro by with short TSLP We that in of short more to in reactions from is after short TSLP and in the of the long isoform. We also that the effect of short TSLP on human is via an as than STAT5 the long isoform K. et of short and long thymic stromal lymphopoietin isoforms in inflammatory of the and Immunol. PubMed Scopus Google Scholar The expression of both TSLP isoforms in with a long TSLP with the steady the of expression is long produced in we the specific upregulation of long short TSLP in from atopic and K. et of short and long thymic stromal lymphopoietin isoforms in inflammatory of the and Immunol. PubMed Scopus Google Scholar we also observed a of the short TSLP in is in line with for TSLP expression in et cells the of dendritic PubMed Scopus Google Scholar The expression of short TSLP and its potential in are by et P. A. et thymic stromal lymphopoietin expression in the of with PubMed Scopus Google Scholar who that expression be a of TSLP in in a new et et stromal lymphopoietin and dendritic in with Immunol. PubMed Scopus Google Scholar also a potential for TSLP in the proinflammatory they the cytokine is upregulated in from They that in TSLP is of the of of by primary human in with and in this study the authors the 2 data produced in long short TSLP upregulation with for this 1 and It is that in pathologic TSLP expression can also be controlled by important to its et al that the was upregulated in from the long isoform of and that different activity on human cells with the et stromal lymphopoietin activity is in of with Immunol. PubMed Scopus Google Scholar in 2 that TSLP is in 2 and by and in These activity on cells and with the long et stromal lymphopoietin activity is in of with Immunol. PubMed Scopus Google Scholar, et a functional of thymic stromal lymphopoietin in Immunol. Google Scholar We have how in recent the of TSLP and the of the 2 expression in and have been by and the existence of a plethora of mouse to study inflammatory P. W. of inflammatory 1: PubMed Scopus Google Scholar as well as other diseases, in TSLP has a and the short isoform is in the mouse, these are for the of the 2 potential in these pathologies. Thus, be of to examine the differential expression of the 2 isoforms in tissues from with such as inflammation to asthma, or allergic Because of the of long TSLP expression in these diseases, the cytokine has been as a target for with that target TSLP and/or its to is shown that the short isoform of TSLP has important homeostatic functions, this be to long TSLP or in the homeostatic effects of short whereas of short TSLP mediate important effects and proinflammatory leading to the of such as and
No takes yet. Share an insight, caveat, or question.
Tsilingiri et al. (2017) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: